ライフサイエンスコーパス: zinc sulfate

1 ient induction of the gene in this tissue by zinc sulfate.

2 helium had been irrigated with 0.1-0.5 ml 5% zinc sulfate.

3 TA, although they were rendered anosmic with zinc sulfate.

4 mal CTA learning even when made anosmic with zinc sulfate.

5 y supplements for 6 mo: 3, 7, or 10 mg Zn as zinc sulfate, 10 mg Zn + 0.5 mg Cu as copper sulfate, or

6 ) mice were administered three oral doses of zinc sulfate (2.5 mg zinc ion/kg body weight) every 12 h

7 alf were supplemented intraperitoneally with zinc sulfate (5 mg/kg) every other day for 3 months.

8 cted soil samples by centrifuge-flotation in Zinc Sulfate, and molecular analysis by PCR identified o

9 the mixed cell-free fractions with 100 mM of zinc sulfate as a precursor.

10 sequestration of zinc ions since addition of zinc sulfate blocked aspirin-mediated apoptosis and repr

11 almitate/d) or vitamin A + zinc (10 or 20 mg zinc sulfate/d) compared with placebo to optimize vitami

12 were treated with intranasal application of zinc sulfate during the first two postnatal weeks, which

13 idazolium-based additive to a cost-effective zinc sulfate electrolyte, which bonds with polyiodides t

14 diarrhea to receive 5 mg, 10 mg, or 20 mg of zinc sulfate for 14 days.

15 re formed by controlled injection of aqueous zinc sulfate into a sodium silicate solution.

16 Aqueous zinc sulfate labeled with 70Zn or 68Zn was orally admini

17 Permanent zinc sulfate lesion of the olfactory epithelium resulted

18 nges could be caused by OSN axon loss in the zinc sulfate lesion, or to a reduced activity.

19 s block-randomized into placebo (n = 39) and zinc sulfate (n = 28) groups collected over a zinc suppl

20 ndomly assigned to receive a 10-mg tablet of zinc sulfate or placebo twice a day during hospitalizati

21 mixture of fortificants containing NaFeEDTA, zinc sulfate or zinc methionine, ascorbic acid, and citr

22 (FP), we have demonstrated that a mixture of zinc sulfate, phosphate-buffered saline, and bovine seru

23 d continually increased, with zinc oxide and zinc sulfate showing the largest increases.

24 Upon stimulation with zinc sulfate, the transgene was expressed in the mammary

25 Zinc sulfate was injected intraperitoneally in a dosage

26 nc gluconate, zinc lactate, zinc acetate, or zinc sulfate yielded inactivation rates of 0 to 55%.

27 time course of anatomical recovery following zinc sulfate (ZnSO(4)) lesion of ORNs in adult male Spra

28 distinguish between the ZnO NP exposures and zinc sulfate (ZnSO4) exposures at equitoxic concentratio